Table 1.
Study characteristics
| Item | Category | All studies (n = 28) [n (%)] |
|---|---|---|
| Country of DCEa | Australia | 2 (7) |
| Canada | 3 (11) | |
| France | 2 (7) | |
| Germany | 4 (14) | |
| Netherlands | 4 (14) | |
| South Korea | 1 (4) | |
| Spain | 1 (4) | |
| Thailand | 1 (4) | |
| UK | 4 (14) | |
| USA | 10 (36) | |
| Year of publication | 2010 | 1 (4) |
| 2011 | 4 (14) | |
| 2012 | 7 (25) | |
| 2013 | 3 (11) | |
| 2014 | 6 (21) | |
| 2015 | 5 (18) | |
| 2016 | 2 (7) | |
| Target populationa | General population | 1 (4) |
| Children | 1 (4) | |
| Parents | 2 (7) | |
| Adults | 25 (89) | |
| Elderly | 9 (32) | |
| Physicians/healthcare provider | 5 (18) | |
| Othersa | 2 (7) | |
| Cancer type of interest | Breast | 8 (30) |
| Gastrointestinal stromal tumour | 1 (4) | |
| Lung | 2 (7) | |
| Lymphoma | 1 (4) | |
| (Low-risk) basal cell carcinoma | 2 (7) | |
| Oesophageal | 2 (7) | |
| Ovarian | 1 (4) | |
| Prostate | 1 (4) | |
| Renal cell carcinoma | 2 (7) | |
| Thyroid | 1 (4) | |
| Combination of different cancer types | 7 (25) | |
| N of attributes per study | 4 | 6 (21) |
| 5 | 6 (21) | |
| 6 | 5 (18) | |
| 7 | 4 (14) | |
| 8 | 5 (18) | |
| 11 | 2 (7) | |
| Average n of attributes | Total | 6.19 |
| Outcome | 4.36 | |
| Process | 1.50 | |
| Cost | 0.32 |
DCE discrete choice experiment
aMore than one category per study possible